{'52WeekChange': None,
 'SandP52WeekChange': None,
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 136.41,
 'askSize': 1800,
 'averageDailyVolume10Day': 3261212,
 'averageVolume': 3649182,
 'averageVolume10days': 3261212,
 'beta': None,
 'beta3Year': 1.01,
 'bid': 135.8,
 'bidSize': 800,
 'bookValue': None,
 'category': 'Health',
 'circulatingSupply': None,
 'companyOfficers': [],
 'currency': 'USD',
 'dayHigh': 138.3,
 'dayLow': 135.21,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': None,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 137.10542,
 'fiftyTwoWeekHigh': 146.53,
 'fiftyTwoWeekLow': 92.15,
 'fiveYearAverageReturn': 0.0253,
 'fiveYearAvgDividendYield': None,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fundFamily': 'iShares',
 'fundInceptionDate': 981331200,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': None,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': 'Exchange Traded Fund',
 'logo_url': '',
 'longBusinessSummary': 'The investment seeks to track the investment results '
                        'of the NASDAQ Biotechnology Index, which contains '
                        'securities of companies listed on NASDAQ that are '
                        'classified according to the Industry Classification '
                        'Benchmark as either biotechnology or pharmaceuticals '
                        'and that also meet other eligibility criteria '
                        'determined by Nasdaq, Inc.\n'
                        ' The fund generally invests at least 90% of its '
                        'assets in securities of the index and in depositary '
                        'receipts representing securities of the index. It may '
                        'invest the remainder of its assets in certain '
                        'futures, options and swap contracts, cash and cash '
                        'equivalents. It is non-diversified.',
 'longName': 'iShares Nasdaq Biotechnology ETF',
 'market': 'us_market',
 'marketCap': None,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_8797590',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': None,
 'navPrice': 139.21,
 'netIncomeToCommon': None,
 'nextFiscalYearEnd': None,
 'open': 138.01,
 'openInterest': None,
 'payoutRatio': None,
 'pegRatio': None,
 'phone': '800-474-2737',
 'previousClose': 139.47,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': None,
 'quoteType': 'ETF',
 'regularMarketDayHigh': 138.3,
 'regularMarketDayLow': 135.21,
 'regularMarketOpen': 138.01,
 'regularMarketPreviousClose': 139.47,
 'regularMarketPrice': 138.01,
 'regularMarketVolume': 3652562,
 'revenueQuarterlyGrowth': None,
 'shortName': 'iShares Nasdaq Biotechnology In',
 'startDate': None,
 'strikePrice': None,
 'symbol': 'IBB',
 'threeYearAverageReturn': 0.1069,
 'totalAssets': 9521329152,
 'tradeable': False,
 'trailingAnnualDividendRate': 0.26,
 'trailingAnnualDividendYield': 0.0018642001,
 'trailingEps': None,
 'twoHundredDayAverage': 123.73892,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'ca55d5b5-742b-33dc-915f-a86fa1a24b91',
 'volume': 3652562,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'yield': 0.0023,
 'ytdReturn': None}